To examine the association between hospitalization, critical illness, and infection occurring during middle-and late-life and structural brain abnormalities in older adults. DESIGN: Prospective cohort study. SETTING: Atherosclerosis Risk in Communities (ARIC) Study. PARTICIPANTS: A community sample of adults who were 44 to 66 years of age at study baseline. MEASUREMENTS: Active surveillance of local hospitals and annual participant contact were used to gather hospitalization information (including International Classification of Diseases, Ninth Revision, codes) on all participants over a 24-year surveillance period. Subsequently, a subset of participants underwent 3-Tesla brain magnetic resonance imaging (MRI) to quantify total and regional brain volumes, white matter hyperintensity (WMH) volume, and white matter microstructural integrity (fractional anisotropy (FA) and mean diffusivity (MD) as measured using diffusion tensor imaging (DTI)). RESULTS: Of the 1,689 participants included (mean age at MRI 76±5), 72% were hospitalized, 14% had a major infection, and 4% had a critical illness during the surveillance period. Using covariate-adjusted regression, hospitalization was associated with 0.12-standard deviation (SD) greater WMH volume (95% confidence interval (CI)=0.00-0.24) and poorer white matter microstructural integrity (0.17-SD lower FA, 95% CI=-0.27 to -0.06; 0.16-SD greater MD, 95% CI=0.07-0.25) than no hospitalization. There was a dose-dependent relationship between number of hospitalizations, smaller brain volumes, and lower white matter integrity (p-trends ≤.048). In hospitalized participants, critical illness was associated with smaller Alzheimer's disease (AD) signature region (-1.64 cm 3 , 95% CI=-3.16 to -0.12); major infection was associated with smaller AD signature region (-1.28 cm 3 , 95% CI=-2.21 to -0.35) and larger ventricular volume (3.79 cm 3 , 95% CI= 0.81-6.77). CONCLUSIONS: Whereas all-cause hospitalization was primarily associated with lower white matter integrity, critical illness and major infection were associated with smaller brain volume, particularly within regions implicated in AD.
A ccumulating evidence suggests that acute illness may play a significant and previously unrecognized role in promoting or accelerating neurodegenerative disease in older adults. 1, 2 Specifically, hospitalization, 3 critical illness, 4 and acute infection 5 have been linked to subsequent cognitive decline and incident dementia, although the mechanism for these associations is poorly understood. One hypothesis is that events associated with hospitalization may initiate or exacerbate pathophysiological processes that underlie structural neurodegenerative changes, increasing the risk of cognitive and functional decline and, ultimately, dementia.
In support of this hypothesis, our group has published results from the Atherosclerosis Risk in Communities (ARIC) Study demonstrating a link between hospitalization over an 11-year period and both cognitive decline and large ventricular size, 1 but participants in this initial study were generally younger than 75, the hospitalization surveillance period was relatively brief, and measures of white matter (WM) microstructural integrity were unavailable. Since this previous report, 1 an older and significantly larger group of participants (some of whom contributed data to our prior paper) have returned for 3-Tesla brain magnetic resonance imaging (MRI) as part of the ARIC Neurocognitive Study. This has allowed us to examine the effects of hospitalization, critical illness, and infection over a 24-year period on the underlying brain structure of a biracial cohort of adults transitioning from midlife to older adulthood. Using a large sample of community-dwelling individuals, we tested the hypothesis that hospitalization, particularly for critical illness and major infection, is associated with smaller total and regional brain volume, greater WM hyperintensity (WMH) volume, and lower WM microstructural integrity in older adults.
METHODS

Study population
We analyzed data from the ARIC Study, an ongoing community-based prospective study, that initially enrolled 15,792 participants aged 45 to 64 from 1987 to 1989 (Visit 1). Participants were selected from four U.S. communities: Washington County, Maryland; Forsyth County, North Carolina; northwestern suburbs of Minneapolis, Minnesota; and Jackson, Mississippi. 6 Participants underwent a baseline examination (Visit 1) and 4 additional in-person follow-up examinations (Visits 2-5; Figure 1 ). Structured interviews and medical examinations were conducted at each visit. The institutional review boards at each participating center approved the ARIC Study protocols. All participants gave written informed consent.
A subset of participants (n=1,978) who attended Visit 5 underwent brain MRI after their medical examination. See Supplementary Appendix S1 for the detailed MRI selection criteria. Briefly, we excluded all participants with MRI contraindications and selected all participants who participated in the Brain MRI Ancillary Study (2004-06). All participants with evidence of cognitive impairment at Visit 5 (2011-13) and an age-stratified random sample of participants without cognitive impairment were also included. 7 Additional study inclusion and exclusion criteria are described in Figure 1 .
Measurement of hospitalization variables
Information on hospitalization events (yes/no, total number) was obtained from annual telephone contact with participants and active surveillance of local hospitals between Visits 1 and 5. Trained staff reviewed and abstracted all hospitalization discharge codes. Using International Classification of Diseases, Ninth Revision (ICD-9) codes, we applied a methodology described previously 8 to identify the presence of critical illness during each hospitalization (yes/no). Critical illness was classified as any one of the following: shock, severe sepsis, acute respiratory failure, hypotension, respiratory or cardiac arrest, cardiopulmonary resuscitation, and prolonged ventilation. We also classified each hospitalization as including a major infection (yes/no) using ICD-9 codes for septicemia, bacterial infection, and pneumonia, as categorized using clinical classification software. We also defined a second hospitalized infection variable that included major and nonmajor infection for exploratory purposes (Supplementary Appendix S1).
Brain MRI
The acquisition sequence for ARIC Visit 5 3-Tesla MRI has been described previously. 7 At each ARIC site, a common set of sequences was performed for all participants: magnetization-prepared rapid acquisition gradient echo (MP-RAGE), axial T2*gradient echo, axial T2 fluidattenuated inversion recovery (FLAIR), and axial diffusion tensor imaging (DTI). Brain volume was measured from MP-RAGE sequences using Freesurfer (http://surfer.nmr. mgh.harvard.edu). 9 We evaluated total brain, ventricular, and Alzheimer's disease (AD) signature region volumes. AD signature region was derived by calculating the combined volumes of the parahippocampal gyrus, entorhinal cortex, Figure 1 . Study flow diagram and inclusion and exclusion criteria. Study visits, assessments, and participant numbers are tabulated.
inferior parietal lobules, hippocampus, and precuneus. 10 WMH volume (mm 3 ) was assessed quantitatively from FLAIR images using a computer-aided segmentation program. 11 All analyses were adjusted for total intracranial volume. Fractional anisotropy (FA) and mean diffusivity (MD) of lobar WM were calculated from the DTI sequences, as described previously (Supplementary Appendix S1). 12 Lower FA and higher MD are associated with poorer WM microstructural integrity. We used standardized measures of FA and MD for total brain WM.
Covariate Assessment
Participant race and center (white-MD, white-MN, white-NC, black-NC, black-MS), sex, and educational attainment (<high school; high school, GED, vocational school; any college) were documented based on self-report (current, former, never). At baseline, body mass index (BMI) was calculated using recorded height and weight (kg/m 2 ), total cholesterol and triglycerides were measured using the enzymatic method 13 , and high-density lipoprotein cholesterol was calculated using dextran-magnesium precipitation.
14 Apolipoprotein E (APOE) was genotyped using the TaqMan assay (Applied Biosystems, Foster City, CA). Alcohol and cigarette use were documented at Visits 1 and 5 based on self-report (current, former, never).
The following were assessed at each study visit. Hypertension was defined as use of antihypertensive medication, systolic blood pressure greater than 140 mmHg, or diastolic blood pressure greater than 90 mmHg. Diabetes was defined as participant report of physician-diagnosed diabetes, current use of diabetes medication, fasting glucose of 126 mg/dL or more, or non-fasting glucose of 200 mg/dL or more. Coronary heart disease was adjudicated based on medical record documentation or participant self-report of previous myocardial infarction, coronary artery bypass graft, or angioplasty or myocardial infarction determined according to electrocardiography. Heart failure was defined based on medical record evidence of heart failure-related hospitalizations or heart failure medication use within 2 weeks preceding the visit. Chronic kidney disease was defined based on estimated glomerular filtration rate calculated using serum creatinine and demographic characteristics. 15 Prebronchodilator spirometry values were used to define chronic obstructive pulmonary disease. 16 Cancer diagnosis was determined using information from cancer registries and ARIC hospital surveillance. 17 An expert committee adjudicated dementia based on a review of each participant's cognitive and functional status at Visit 5.
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Statistical analysis
Covariate-adjusted linear regression was used to examine the association between hospitalization variables (exposure) and continuous measures of brain volume and WM integrity (outcomes). WMH volume was log-transformed to correct for skewness. First, we compared participants with 1 or more hospitalizations with those with no hospitalization. Second, we examined the effect of multiple hospitalizations by dividing participants into groups based on total number of hospitalizations (0, 1, 2-3, 4-5, ≥6) and comparing each group with the group with no previous hospitalizations. For participants who had been hospitalized, we compared those with critical illness with those with no critical illness and those with a major hospitalized infection with those with no major infection. We used a hospitalized comparison group to separate the effect of critical illness and infection from that of hospitalization more generally. All analyses were adjusted for the following covariates: race and center, education, sex, age at MRI, APOE ε4 allele status (present/ absent), baseline physiological variables (BMI, triglycerides, total cholesterol, high-density lipoprotein cholesterol), smoking and alcohol use status, and prevalent medical comorbidity (hypertension, diabetes, coronary heart disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease) occurring before or during the followup period up to the time of MRI (Visit 5).
Regression analyses incorporated sampling weights to account for the ARIC Visit 5 brain MRI sampling strategy. Therefore, the results presented represent estimates based on the entire ARIC Visit 5 population. We conducted several sensitivity analyses. To examine the potential for reverse causation, we repeated analyses after omitting participants with incident dementia and those who scored below the 5th percentile on a midlife (Visit 2) measure of global cognitive status. We also repeated analyses after omitting participants with clinical stroke before Visit 5. Lastly, as an alternative method to control for confounding while mitigating bias related to differential attrition, we calculated propensity scores 19 for attrition and for each hospitalization event, used these propensity scores to match and compare participants from distinct exposure groups, and incorporated propensity scores as covariates into fully adjusted regression models (Supplementary Appendix S1). 20 Two-sided p<.05 was used as the indication for statistical significance. All analyses were conducted using Stata version 14 (Stata Corp, College Station, TX).
RESULTS
We analyzed data from 1,689 participants with a mean baseline age of 52.7±5.2; 60% were female, and 28% were black. The average time between Visit 1 and brain MRI (Visit 5) was 24±1 years. At Visit 5 (mean age 76.3±5.3), 5% of participants met criteria for dementia. Seventy-two percent (n=1,214) of participants were hospitalized during the follow-up period. Participants who were hospitalized during follow-up had higher BMI; lower diastolic blood pressure, cholesterol, and low-density lipoprotein cholesterol; were more likely to use cholesterol-lowering medication; and had a greater rate of medical comorbidity at the time of MRI than those who were not (Table 1) .
Hospitalization and late-life MRI variables
Participants with 1 or more hospitalizations had greater WMH volume and lower WM microstructural integrity (FA and MD values) but not smaller brain volume (Table 2) , than those with no hospitalization, even after omitting participants with critical illness and major infection. These findings were largely unchanged in magnitude and direction in analyses that excluded participants with incident dementia, midlife cognitive impairment, and clinical stroke (Supplementary Tables S1-3) . We found a dose-dependent relationship between number of hospitalizations and greater WMH volume, lower WM microstructural integrity, and smaller total and regional brain volumes ( Figure 2 , Table 3,  Supplementary Table S4 , Supplementary Figure S1 ). Although significantly lower WM integrity was observed in individuals with 2 to 3 hospitalizations, significantly smaller brain volumes were detectable only in participants with 4 to 5 hospitalizations.
Critical illness and late-life MRI variables
Four percent (n=47) of hospitalized participants had 1 or more critical illnesses during follow-up. Participants hospitalized for critical illness did not differ from those hospitalized for noncritical illness on measures of WM integrity, although participants with critical illness had 3% smaller AD signature region volumes (p<.05) ( Table 2 ). In our regression model, the magnitude of the effect of critical illness on AD signature region volume was more than twice that of a single APOE ε4 allele (see footnote in Table 2 ). No group differences were found on measures of total or ventricular volume. Associations between critical illness and brain volume were similar after excluding participants with midlife cognitive impairment and incident dementia but were attenuated after omitting individuals with clinical stroke (Supplementary Tables S1-3) .
Hospitalized infection and late-life MRI variables
Fourteen percent (n=165) of hospitalized participants had 1 or more major hospitalized infections. Participants with a major infection did not differ from those hospitalized with no Groups were compared using t-tests and chi-square tests. a p < .05 for difference between the hospitalization and non-hospitalization group. SD = standard deviation.
major infection on measures of WM integrity but had 2% smaller AD signature region volumes and 10% larger ventricular volumes (p's<.05) ( Table 2 ). The magnitude of the effect of hospitalized infection on AD signature region volume was approximately 1.5 that of a single APOE ε4 allele. Findings were largely similar after excluding participants with midlife Analyses were adjusted for age, sex, race and center, education, apolipoprotein E (APOE) ε4 status, cigarette smoking and alcohol use status, body mass index, total cholesterol, high-density lipoprotein cholesterol, triglycerides, prevalent medical comorbidity (hypertension, diabetes, coronary heart disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, cancer), and Visit 5 intracranial volume. β represents the estimated mean difference between groups being compared, adjusting for potential confounders. Tables S1-3 and S5) . Infection, defined more broadly to include major and nonmajor hospitalized infections (n=297), was associated with 6% greater ventricular volume but was unrelated to AD signature region volume (Supplementary Table S6 ).
Sensitivity analyses using propensity score methods
Our results were largely similar to those of the primary analyses with regard to statistical significance and direction of association, irrespective of whether propensity score matching or propensity score covariate adjustment was used (Supplementary Tables S7, 8 ), although several of the coefficients derived from propensity score-matched analyses were larger.
DISCUSSION
Using a community-based prospective study, we have shown that all-cause hospitalization, critical illness, and infection are each associated with evidence of MRI-defined structural brain abnormalities in a large sample of older adults. Specifically, participants with 1 or more hospitalizations during a 24-year surveillance period spanning from middle to late life who survived into older adulthood had greater WMH volume and less WM microstructural integrity as older adults. We also found evidence of a dosedependent relationship between number of hospitalizations and late-life MRI measures. Although significant reductions in total and regional brain volume were observed only in participants with 4 or more hospitalizations, less WM integrity was found in participants with as few as 2 hospitalizations. Participants who were hospitalized and experienced a critical illness or a major infection had smaller brain volumes in regions vulnerable to AD in late life. The estimated effects of critical illness and infection on these brain regions was approximately 2 and 1.5 times that of a single APOE ε4 allele, respectively. To provide context, a single APOE ε4 allele is associated with a triple the risk of AD and age of AD onset 10 years earlier than that of older adults without an APOE ε4 allele. 21 Our findings were observed after adjusting for demographic and physiological variables, medical comorbidity, and APOE genotype and remained after participants with dementia were excluded.
In addition to replicating and extending previous findings linking all-cause hospitalization to reductions in WM integrity and brain volume, 1 the current results build upon those of previous studies that have identified critical illness 22 and infection 2,23 as risk factors for incident dementia. WM abnormalities and brain volume loss are markers of some of the pathological brain changes which underlie cognitive decline and dementia. Thus, our findings support the idea that critical illness and infection promote neurodegenerative brain changes that may, in turn, set the stage for late-life cognitive and functional decline. Loss of brain volume in AD-relevant regions presumably reduces the threshold at which AD pathology induces overt clinical symptoms. Stroke may partially account for the effects of critical illness on brain volume, because the magnitude of these associations was attenuated after excluding stroke cases. Nevertheless, the association between major infection and smaller brain volume was independent of stroke and critical illness. Infection, even when broadly defined to include mild or non-life-threatening infections, was associated with brain volume loss, albeit to a lesser extent than major infection. Although participants with 1 or more hospitalizations had greater WMH volume and DTI diffusion abnormalities than those who were not hospitalized, we did not find evidence of the emergence of additional WM abnormalities attributable to critical illness or infection.
The current study is unique in that it compared participants with critical illness and infection with a hospitalized control group, allowing us to separate the neurological sequelae associated with each of these exposure variables from those of hospitalization more broadly. In addition, the current study had a long follow-up period, which allowed us to capture hospitalization events and incident medical comorbidity over a 2-to 3-decade period beginning in midlife. This is of importance given that it is suspected that the neurodegenerative processes that our hospitalization variables may influence begin during midlife and gradually evolve over decades 24 and that the midlife disease and vascular risk factors that increase the risk of hospitalization have also been associated with late-life neurodegenerative changes. 25 Thus, the extended study design allowed us to Analyses were adjusted for age, sex, race and center, education, apolipoprotein E ϵ4 status, cigarette smoking and alcohol use status, body mass index, total cholesterol, high-density lipoprotein cholesterol, triglycerides, prevalent medical comorbidity (hypertension, diabetes, coronary heart disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, cancer), and Visit 5 intracranial volume. β represents the estimated mean difference between the hospitalization groups and the no-hospitalization reference group after adjusting for potential confounders.
adjust for midlife risk factors and incident medical comorbidity to reduce the likelihood of confounding. A series of sensitivity analyses that used propensity score methods to address confounding while also adjusting for bias related to informative censoring further supported our findings. Hospitalization, critical illness, and infection may contribute to neurodegenerative brain changes by promoting inflammation in the periphery and the central nervous system. Infection and tissue damage result in the induction of pro-inflammatory mediators throughout the body. 26, 27 Systemic inflammation has been associated with smaller brain volume 28 and WM integrity 29 and is believed to contribute to neuronal and glial dysfunction by promoting neuroinflammation and Alzheimer's pathology, 30 blood-brain barrier dysfunction, 31 and changes in cerebral metabolism. 32 Additional factors associated with hospitalization, such as delirium 4 and iatrogenic medication effects 33 , may also explain the associations observed in the present study, although caution must be exercised in making causal inferences from the current findings, because there are plausible alternative explanations. For example, cognitive decline may place individuals at greater risk of hospitalization, infection, and critical illness 34 , although this is unlikely to explain the current results, because our findings did not change after excluding individuals with incident dementia or midlife cognitive impairment. Alternatively, hospitalization may be an indicator of a multisystem aging phenotype (e.g., frailty), which itself may promote structural brain abnormalities.
The current study has several strengths, including use of a large community sample, a long follow-up and surveillance period, rigorous assessment of medical comorbidity, and use of a hospitalized control group. There are also several limitations. First, because we relied on ICD-9 codes rather than chart review to identify critical illness and infection, our analyses may be subject to exposure misclassification, although ICD-9 codes have been shown to identify such variables with a high level of sensitivity. 35 Second, lack of information about potentially relevant hospital events, such as delirium, limited our analyses. Third, without baseline brain MRIs, it is impossible to be certain that hospitalization events predated reductions in brain volume and WM integrity. Fourth, our analysis of multiple outcome variables increases the likelihood of type 1 error, so replication will be necessary to corroborate the current findings. Last, despite our attempts to account for bias using multivariable regression and propensity score methods, our results may be subject to bias related to differential rates of death and study dropout (informative censoring; Supplementary  Table S9 ) and residual confounding from indication bias or unmeasured variables. In particular, a higher rate of attrition of participants with more hospitalization events, major infection, and critical illness may have biased the findings in favor of the null hypothesis. Despite these limitations, our findings provide insight into the previously described link between hospitalization, critical illness, infection, and dementia. By demonstrating an association between hospitalized events and abnormalities in brain structure, our results highlight the potential role of hospitalization, critical illness, and infection in the pathological processes underlying cognitive decline and neurodegenerative disease.
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